Sign In
Buy MRNA
$51.59
+2.53 (+5.16%)
At Close: Jun 04, 2026
Can Moderna Keep the Beat Streak Alive This Earnings Season?
01:00pm, Friday, 25'th Apr 2025
When MRNA reports first-quarter earnings, investors will likely focus on pipeline updates.
Moderna (MRNA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
11:08am, Thursday, 24'th Apr 2025
Moderna (MRNA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Where Will Moderna Be in 5 Years?
03:10pm, Sunday, 20'th Apr 2025
In the early days of the COVID-19 pandemic, Moderna (MRNA -1.89%) was a top performer, from both a share-price and an earnings perspective. As one of the leading coronavirus vaccine companies, the bio
Moderna (MRNA) Stock Drops Despite Market Gains: Important Facts to Note
06:56pm, Thursday, 17'th Apr 2025
Moderna (MRNA) reachead $24.73 at the closing of the latest trading day, reflecting a -1.85% change compared to its last close.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
09:55am, Monday, 14'th Apr 2025
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Moderna to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025
07:00am, Thursday, 10'th Apr 2025
CAMBRIDGE, MA / ACCESS Newswire / April 10, 2025 / Moderna, Inc. (NASDAQ:MRNA), today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday, May 1, 2025 to report
Why Moderna Stock Was Down 31.8% in Q1 as the S&P 500 Had Its Worst Quarter Since 2022
07:25pm, Tuesday, 08'th Apr 2025
The first quarter of 2025 was a tough one. The S&P 500 lost 4.6%, and the Nasdaq Composite lost 10.4%.
Moderna to Showcase Extensive Infectious Disease Research at ESCMID 2025
07:00am, Monday, 07'th Apr 2025
CAMBRIDGE, MA / ACCESS Newswire / April 7, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Company will present research across multiple infectious disease areas, including COVID-19, influ
Better Beaten-Down Stock to Buy: Pfizer Vs. Moderna
08:30am, Thursday, 03'rd Apr 2025
In 2020, many companies tried to develop effective coronavirus vaccines, but two ended up succeeding and dominating the field: Pfizer (PFE 0.77%) and Moderna (MRNA 2.21%). These two vaccine makers mad
FDA News Just Shook Moderna. Is the Stock One to Avoid or a Bad-News Buy?
04:08am, Thursday, 03'rd Apr 2025
Moderna (MRNA 2.21%) has gone through its share of ups and downs in recent years, from posting soaring coronavirus vaccine revenue a few years ago to seeing demand for that product sink in the later s
Trump's tariffs are a new challenge for Big Pharma. Here are the best positioned stocks
02:01pm, Tuesday, 01'st Apr 2025
Leerink Partners analyst David Resinger warned his clients on Sunday that the tariff risks to the industry are 'underappreciated.'
Biotech Stocks Fall After Top FDA Official Quits Over Clash With RFK Jr.
08:25am, Tuesday, 01'st Apr 2025
The decline in biotech stocks comes after FDA official Peter Marks' resignation, citing irreconcilable differences with the new HHS Secretary.
Vaccine stocks fall following FDA resignation
06:21pm, Monday, 31'st Mar 2025
Dr. Kavita Patel joins 'Fast Money' to talk the impact of FDA and HHS changes on vaccines, public health policy, and more.
S&P 500 Gains and Losses Today: Moderna Stock Plunges After Resignation of FDA Vaccine Official
05:01pm, Monday, 31'st Mar 2025
Major U.S. equities indexes were mixed to kick off the new trading week as U.S. trade policy remained in focus.
Vaccine stocks tumble: Moderna, Novavax, Pfizer fall after top FDA official resigns over RFK Jr. anti-vax views
02:41pm, Monday, 31'st Mar 2025
Stocks of major vaccine makers dropped on Monday after the Food and Drug Administration's (FDA) top vaccine official Dr. Peter Marks resigned, citing conflicts with Health and Human Services (HHS) Sec
